EU-GMP Indoor Flower · GACP + EU-GMP
- Margin
- 2.8x - 3.4x
- Execute
- 4 - 8 weeks
- Confidence
- High · 92%
- Friction
- Low
- Velocity
- 4 / 5
- Catalyst
- Bilateral agreements, GMP-certified pipeline, Canadian cost disadvantage
GLOBAL TRADE INTELLIGENCE
Where supply is moving, what margins exist, and whether corridors are expanding or collapsing. Execution-grade trade intelligence across the global cannabis market.
CID Take — Corridor Intelligence
LatAm-to-EU flower corridors expanded 48% in Q1. Israel tariffs collapsed the Canada-Israel route, redirecting volume to Colombia. Thai medical exports to APAC accelerating.
Supply pressure concentrating on Colombia and South Africa export corridors. Demand surging in Germany and Israel post-regulatory shifts. Canada facing structural cost disadvantage.
Expanding flows indicate new corridor formation. Compressing flows signal oversupply or regulatory friction. Most margins above 3x will not persist beyond 60-90 days.
Ranked Corridor Board
Corridor intelligence based on verified trade conditions. No supplier names. Click any corridor for compliance and risk detail.
EU-GMP Indoor Flower · GACP + EU-GMP
Medical Flower · SAHPRA + EU-GMP (pipeline)
Medical Cannabis · Thai FDA + TGA Pathway
EU-GMP Dried Flower · Health Canada + EU-GMP
Full access to all live flow data, velocity tracking, friction scores, and corridor intelligence. Free for qualified buyers.